19 research outputs found

    Synthesis of iridaoxaphospholane complexes

    Get PDF
    Financiaciado para publicación en acceso aberto: Universidade de Vigo/CISUGAn alkenylphosphinite compound has been used to synthesize the unknown iridaoxaphospholane complexes which have been characterized in solution and solid state. The reactions took place in mild conditions and the product were obtained in good yields. The synthesis of the iridaoxaphospholane complexes is based on the capability of the alkenylphosphinite compound to behave as a κ1P or κ3(P, C, C) ligand when bonded to a metal complex. Theoretical calculations have been performed to explain the formation of the iridaoxaphospholane derivative due to a lower energy barrier for the nucleophilic attack at the terminal carbon of the olefin.Xunta de Galicia | Ref. GRC2019/2

    Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

    No full text

    Alirocumab and cardiovascular outcomes after acute coronary syndrome

    No full text
    BACKGROUN

    Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

    No full text

    Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

    No full text
    BACKGROUN

    Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

    No full text

    Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial

    No full text

    Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

    No full text
    10.1161/CIRCULATIONAHA.119.042551CIRCULATION140191578-158

    Alirocumab reduces total hospitalizations and increases days alive and out of hospital in the ODYSSEY OUTCOMES trial

    No full text

    Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

    No full text
    corecore